346 related articles for article (PubMed ID: 28442450)
1. Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.
Hay JL; Berwick M; Zielaskowski K; White KA; Rodríguez VM; Robers E; Guest DD; Sussman A; Talamantes Y; Schwartz MR; Greb J; Bigney J; Kaphingst KA; Hunley K; Buller DB
JMIR Res Protoc; 2017 Apr; 6(4):e52. PubMed ID: 28442450
[TBL] [Abstract][Full Text] [Related]
2. Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.
Hay JL; Zielaskowski K; Meyer White K; Kaphingst K; Robers E; Guest D; Sussman A; Talamantes Y; Schwartz M; Rodríguez VM; Li Y; Schofield E; Bigney J; Hunley K; Buller D; Berwick M
JAMA Dermatol; 2018 Jun; 154(6):684-693. PubMed ID: 29801061
[TBL] [Abstract][Full Text] [Related]
3. The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Smit AK; Newson AJ; Morton RL; Kimlin M; Keogh L; Law MH; Kirk J; Dobbinson S; Kanetsky PA; Fenton G; Allen M; Butow P; Dunlop K; Trevena L; Lo S; Savard J; Dawkins H; Wordsworth S; Jenkins M; Mann GJ; Cust AE
Contemp Clin Trials; 2018 Jul; 70():106-116. PubMed ID: 29802966
[TBL] [Abstract][Full Text] [Related]
4. Behavioral and Psychological Outcomes Associated with Skin Cancer Genetic Testing in Albuquerque Primary Care.
Hay JL; Kaphingst KA; Buller D; Schofield E; Meyer White K; Sussman A; Guest D; Dailey YT; Robers E; Schwartz MR; Li Y; Hunley K; Berwick M
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439206
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial and Cultural Determinants of Interest and Uptake of Skin Cancer Genetic Testing in Diverse Primary Care.
Hay JL; Meyer White K; Sussman A; Kaphingst K; Guest D; Schofield E; Dailey YT; Robers E; Schwartz MR; Zielaskowski K; Li Y; Buller D; Hunley K; Berwick M
Public Health Genomics; 2019; 22(1-2):58-68. PubMed ID: 31437847
[TBL] [Abstract][Full Text] [Related]
6. Response Across the Health-Literacy Spectrum of Kidney Transplant Recipients to a Sun-Protection Education Program Delivered on Tablet Computers: Randomized Controlled Trial.
Robinson JK; Friedewald JJ; Desai A; Gordon EJ
JMIR Cancer; 2015 Aug; 1(2):e8. PubMed ID: 28410176
[TBL] [Abstract][Full Text] [Related]
7. A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Smit AK; Espinoza D; Newson AJ; Morton RL; Fenton G; Freeman L; Dunlop K; Butow PN; Law MH; Kimlin MG; Keogh LA; Dobbinson SJ; Kirk J; Kanetsky PA; Mann GJ; Cust AE
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):212-221. PubMed ID: 27702805
[TBL] [Abstract][Full Text] [Related]
8. Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care.
Rodríguez VM; Robers E; Zielaskowski K; Javier González C; Hunley K; Kaphingst KA; Guest DD; Sussman A; Meyer White KA; Schwartz MR; Greb J; Talamantes Y; Bigney J; Berwick M; Hay JL
J Community Genet; 2017 Jan; 8(1):53-63. PubMed ID: 27924449
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.
Coups EJ; Manne SL; Ohman Strickland P; Hilgart M; Goydos JS; Heckman CJ; Chamorro P; Rao BK; Davis M; Smith FO; Thorndike FP; Ritterband LM
Contemp Clin Trials; 2019 Aug; 83():117-127. PubMed ID: 31255801
[TBL] [Abstract][Full Text] [Related]
10. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial.
Hacker E; Horsham C; Vagenas D; Jones L; Lowe J; Janda M
JMIR Mhealth Uhealth; 2018 Nov; 6(11):e199. PubMed ID: 30487115
[TBL] [Abstract][Full Text] [Related]
11. Personalized melanoma risk assessments and tailored prevention advice: a pragmatic randomized controlled trial in Australian general practice.
Vuong K; Armstrong BK; McGeechan K; Cust AE
Fam Pract; 2019 Mar; 36(2):237-246. PubMed ID: 29800131
[TBL] [Abstract][Full Text] [Related]
12. Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General Population.
Fenton GL; Smit AK; Freeman L; Badcock C; Dunlop K; Butow PN; Kirk J; Cust AE
J Genet Couns; 2018 Apr; 27(2):370-380. PubMed ID: 29199389
[TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of precision prevention materials incorporating
Lacson JCA; Doyle SH; Del Rio J; Forgas SM; Carvajal R; Gonzalez-Calderon G; Feliciano AR; Kim Y; Roetzheim RG; Sutton SK; Vadaparampil ST; Soto-Torres B; Kanetsky PA
Cancer Res Commun; 2022 Jan; 2(1):28-38. PubMed ID: 35845857
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Trial of Precision Prevention Materials to Improve Primary and Secondary Melanoma Prevention Activities among Individuals with Limited Melanoma Risk Phenotypes.
Lacson JCA; Doyle SH; Qian L; Del Rio J; Forgas SM; Valavanis S; Carvajal R; Gonzalez-Calderon G; Kim Y; Roetzheim RG; Sutton SK; Vadaparampil ST; Kanetsky PA
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201795
[TBL] [Abstract][Full Text] [Related]
15. Comprehension of skin cancer genetic risk feedback in primary care patients.
Khan E; Kaphingst KA; Meyer White K; Sussman A; Guest D; Schofield E; Dailey YT; Robers E; Schwartz MR; Li Y; Buller D; Hunley K; Berwick M; Hay JL
J Community Genet; 2022 Feb; 13(1):113-119. PubMed ID: 34797550
[TBL] [Abstract][Full Text] [Related]
16. Exploring the emotional and behavioural reactions to receiving personalized melanoma genomic risk information: a qualitative study.
Fenton GL; Smit AK; Keogh L; Cust AE
Br J Dermatol; 2019 Jun; 180(6):1390-1396. PubMed ID: 30580464
[TBL] [Abstract][Full Text] [Related]
17. Assessment of melanoma precision prevention materials incorporating MC1R genetic risk information.
Lacson JCA; Forgas SM; Doyle SH; Qian L; Del Rio J; Valavanis S; Carvajal R; Gonzalez-Calderon G; Kim Y; Roetzheim RG; Vadaparampil ST; Kanetsky PA
Transl Behav Med; 2022 May; 12(5):683-687. PubMed ID: 35552458
[TBL] [Abstract][Full Text] [Related]
18. Does personalized melanoma genomic risk information trigger conversations about skin cancer prevention and skin examination with family, friends and health professionals?
Smit AK; Keogh LA; Newson AJ; Butow PN; Dunlop K; Morton RL; Kirk J; Espinoza D; Cust AE
Br J Dermatol; 2017 Sep; 177(3):779-790. PubMed ID: 28627002
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
